COMP <GO>
TVGN vs TNYA // GROSS PROFIT MARGIN
Tevogen Inc. (NASDAQ) VS. Tenaya Therapeutics Inc. (NASDAQ) • 15-METRIC TALLY: TVGN 2
— TNYA 1
■ METRIC PARITY
LAST: $5.90 (-2.48%) • MKT CAP: $95.2M
gross-margins
—
LAST: $0.37 (-7.78%) • MKT CAP: $90.8M
gross-margins
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (TVGN VS. TNYA)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | TVGN | TNYA | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin ACTIVE | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -13.02% | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | — | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 1/9 | 3/9 | -2.00 | TNYA | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 37.1 | 27.5 | +9.62 | TVGN | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $95.2M | $90.8M | $4.4M | TVGN | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | TVGN REV | TNYA REV | TVGN GROSS % | TNYA GROSS % | TVGN FCF | TNYA FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $0 | $0 | — | — | -$12.4M | -$68.9M |
| FY 2024 | $0 | $0 | — | — | -$12.0M | -$91.5M |
| FY 2023 | $0 | $0 | — | — | -$8.2M | -$102.1M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
TVGN // BETA —
TNYA // BETA —